Using androgen-insensitive DU145 prostate cancer cells, which have higher endogenous ezrin expression (Figure 6A), we knocked down ezrin and observed cells under SEM to investigate the effect on TNT and EV morphology. The gene discussed is EZR; the disease is prostate carcinoma.